LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $29,827,000 | -49.7% | 219,803 | +1.7% | 1.76% | -33.0% |
| Q3 2018 | $59,318,000 | +35.6% | 216,104 | +2.3% | 2.62% | +16.8% |
| Q2 2018 | $43,744,000 | +46.0% | 211,152 | +16.4% | 2.25% | +33.5% |
| Q1 2018 | $29,956,000 | +22.9% | 181,378 | +1.9% | 1.68% | +19.4% |
| Q4 2017 | $24,379,000 | +8.5% | 178,039 | +7.8% | 1.41% | -1.2% |
| Q3 2017 | $22,479,000 | +14.7% | 165,102 | +2.3% | 1.43% | +5.5% |
| Q2 2017 | $19,597,000 | +70.1% | 161,422 | +48.3% | 1.35% | +56.4% |
| Q1 2017 | $11,522,000 | -35.7% | 108,859 | -38.3% | 0.86% | -44.6% |
| Q4 2016 | $17,932,000 | +12.2% | 176,478 | +12.7% | 1.56% | -4.7% |
| Q3 2016 | $15,981,000 | +207.9% | 156,585 | +259.8% | 1.64% | +135.7% |
| Q2 2016 | $5,191,000 | – | 43,523 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |